advertisement

Topcon

Abstract #20701 Published in IGR 10-1

Treating neovascular glaucoma with intravitreal bevacizumab

Kahook MY; Olson JL
Techniques in Ophthalmology 2007; 5: 150-153


Neovascular glaucoma is a serious ocular condition commonly associated with diabetic retinopathy, central retinal vein occlusions, chronic retinal detachments, and other conditions leading to ischemia of the retina. Vascular endothelial growth factor inhibitors lead to the regression of neovascular vessels when injected into the anterior chamber or vitreous. We describe our technique for intravitreal injection of bevacizumab and expand on the future role of vascular endothelial growth factor inhibitors for treatment of glaucoma.

Dr. M.Y. Kahook, Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado Health Sciences Center, PO Box 6510, Aurora, CO 80045, USA. Malik.kahook@gmail.com


Classification:

9.4.5.1 Neovascular glaucoma (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders > 9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous)



Issue 10-1

Change Issue


advertisement

Oculus